Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
aHSrHpydHT97K03p
Listen
